McGill Iain 4
4 · Jazz Pharmaceuticals plc · Filed Nov 21, 2017
Insider Transaction Report
Form 4
McGill Iain
Head of EUSA Int'l & SVP
Transactions
- Exercise/Conversion
Ordinary Shares
2017-11-17$46.83/sh+8,000$374,640→ 28,383 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-11-17$133.42/sh−8,000$1,067,358→ 4,500 totalExercise: $46.83Exp: 2022-08-08→ Ordinary Shares (8,000 underlying) - Sale
Ordinary Shares
2017-11-17$133.42/sh−8,000$1,067,358→ 20,383 total
Footnotes (2)
- [F1]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $132.95 to $133.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F2]This non-qualified stock option was granted on August 9, 2012 and vested over a period four years from date of grant. The options were fully vested as of August 9, 2016.